Form 4: ChromaDex Director Ann Cohen Acquires 20,000 Stock Options
SEC Form 4 Filing
Director Ann Cohen reports acquisition of 20,000 ChromaDex Corp. stock options.
Summary
- On June 20, 2024, Ann Cohen, a director of ChromaDex Corp., acquired 20,000 stock options with an exercise price of $2.71.
- The options vest 100% on June 20, 2025, and expire on June 19, 2034.
- Following the transaction, Cohen directly owns 20,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.
Positives
- A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of transaction: Ann Cohen acquired 20,000 stock options. |
| 06/20/2025 | Vesting date: Options vest 100%. |
| 06/19/2034 | Expiration date: Options expire. |
| 06/21/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.